AFFYIMMUNE THERAPEUTICS
AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The Company’s proprietary technology may significantly improve the existing CAR-T cell therapy by extending the target of CAR-T therapies to solid tumors using a novel molecule and tuning down the affinity from picomolar to micromolar level to lower the on-target off-tumor toxicity.
AFFYIMMUNE THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.affyimmune.com
Total Employee:
1+
Status:
Active
Contact:
(617) 699-1965
Total Funding:
28.9 M USD
Similar Organizations
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
ORI Capital
ORI Capital investment in Series A - AffyImmune Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-25 | AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development |
Official Site Inspections
http://www.affyimmune.com
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
